Bruker price target raised to $90 from $80 at Citi

Citi analyst Patrick Donnelly raised the firm’s price target on Bruker to $90 from $80 and keeps a Buy rating on the shares after the company reported Q4 revenue and adjusted EPS above the firm’s estimates. The firm, which updated its model to reflect the results and initial FY23 guidance, continues to view Bruker as "having one of the cleanest setups this year" given its backlog and visibility.